Luis Vincenty
Internal Medicine · Mayaguez, PRNPI 1457467714
Payments from drug & device makers
Across 151 payments — averaging $21.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$480
- AbbVie$328
- Johnson & Johnson$318
- Boehringer Ingelheim$224
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$222
- Bayer$169
- plus $2K from 24 others
What the payments were for
- Food & beverage$3,280100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $480 |
| AbbVie | 24 | $328 |
| Johnson & Johnson | 17 | $318 |
| Boehringer Ingelheim | 10 | $224 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $222 |
| Bayer | 7 | $169 |
| E.r. Squibb & Sons, L.L.C. | 2 | $153 |
| Sunovion Pharmaceuticals Inc. | 8 | $146 |
| GSK | 8 | $142 |
| Sanofi-aventis U.S. LLC | 6 | $140 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $134 |
| Novartis | 8 | $133 |
| PBG Puerto Rico LLC | 6 | $119 |
| Boston Scientific | 1 | $71 |
| Abbott | 3 | $66 |
| Novo Nordisk | 4 | $58 |
| Electromed, Inc. | 1 | $57 |
| Biohaven Pharmaceuticals, Inc. | 3 | $53 |
| Lilly USA, LLC | 3 | $48 |
| Daiichi Sankyo Inc. | 2 | $34 |
| Lundbeck LLC | 1 | $28 |
| Urovant Sciences Inc | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Phadia US Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Corcept Therapeutics | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $13 |
| Vanda Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,280 in reported general payments places this provider in the 85th percentile of 1,043 internal medicine providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $18,816 |
| FarxigaDapagliflozin Propanediol | 12 | $12,773 |
| LantusInsulin Glargine,hum.Rec.Anlog | 21 | $3,169 |
| SynthroidLevothyroxine Sodium | 15 | $1,841 |
| Famotidine | 87 | $1,504 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $1,494 |
| HumalogInsulin Lispro | 11 | $1,154 |
| Losartan Potassium | 54 | $703 |
| Sucralfate | 14 | $666 |
| Cefadroxil | 51 | $579 |
| Atorvastatin Calcium | 49 | $576 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $573 |
| Levothyroxine Sodium | 31 | $490 |
| Omeprazole | 46 | $352 |
| Metoprolol Succinate | 25 | $345 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $480 | $12,77312 claims |
| Sanofi-aventis U.S. LLCLantus | $140 | $3,16921 claims |
| AbbVieSynthroid | $328 | $1,84115 claims |
| Lilly USA, LLCHumalog | $48 | $1,15411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,043 internal medicine providers in Puerto Rico.
Other internal medicine in Mayaguez
- Javier TorresMayaguez$10K
- Elizabeth BarrancoPonce$8M
- Grisell Ortiz LasantaSan Juan$5.9M
- Ruben Santiago-LugoGuaynabo$1.3M
- Nelson VallejoLas Piedras$621K
- Ricardo FernandezSan Juan$480K
- Ronald Collazo PaganManati$206K
- Evelyn Matta FontanetRio Grande$200K
- Angel VinuelaDorado$182K
- Lumen Vera ColonAibonito$179K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.